Table 3. HRI and rCBV values calculated at the lesion and contra lateral side VOIs.
Patient No | rCBV | ΔS-O2 (%) | ΔS-CO2(%) | Vascular reactivity index1 | |||||
lesion | CLS | lesion | CLS | lesion | CLS | lesion | CLS | ||
1 | Atypical Meningioma | 8.2 | 1.9 | 3.32 | 2.82 | 1.09 | 0.93 | 19% | 9% |
2 | Glioblastoma | 2.5 | 1.2 | 1.94 | 1.93 | 0.72 | 1.08 | 27% | 7% |
3 | Glioblastoma | 4.1 | NA2 | 1.10 | NA2 | 0.33 | NA2 | 13% | NA2 |
4 | Recurrent Glioblastoma | 2.6 | 1.7 | 1.00 | 2.02 | 0.19 | 0.60 | 12% | 7% |
5 | Recurrent Glioblastoma | 3.7 | 1.9 | 1.05 | 1.93 | 0.38 | 0.87 | 15% | 10% |
6 | Recurrent Glioblastoma | NA3 | NA3 | 1.07 | 1.50 | 0.63 | 0.80 | 2% | 12% |
7 | Recurrent Glioblastoma | NA3 | NA3 | 0.55 | 1.48 | 0.09 | 0.15 | 13% | 43% |
ΔS = percent signal intensity changes; rCBV = relative cerebral blood volume; CLS = contralateral side.
Vascular reactivity index, number of voxels (in percentages) above the defined VRM threshold.
Lesion crosses brain midline, thus contralateral side VOI could not be defined.
DSC perfusion was not performed.